Rankings
▼
Calendar
BEAM Q1 2025 Earnings — Beam Therapeutics Inc. Revenue & Financial Results | Market Cap Arena
BEAM
Beam Therapeutics Inc.
$3B
Q1 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$7M
+0.8% YoY
Gross Profit
-$91M
-1222.8% margin
Operating Income
-$119M
-1596.9% margin
Net Income
-$109M
-1462.8% margin
EPS (Diluted)
$-1.24
QoQ Revenue Growth
-75.2%
Cash Flow
Operating Cash Flow
-$104M
Free Cash Flow
-$107M
Stock-Based Comp.
$27M
Balance Sheet
Total Assets
$1.5B
Total Liabilities
$344M
Stockholders' Equity
$1.1B
Cash & Equivalents
$528M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$7M
$7M
+0.8%
Gross Profit
-$91M
-$77M
-18.0%
Operating Income
-$119M
-$104M
-14.6%
Net Income
-$109M
-$99M
-10.7%
← FY 2025
All Quarters
Q2 2025 →